News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Antares Pharma, Inc. Reports Third Quarter 2006 Financial Results
November 14, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (Amex: AIS) today reported financial results for the three and nine months ended September 30, 2006.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Deals
Novartis, Antares stars align in cancer deal that could top $1.9B
June 24, 2026
·
2 min read
·
Gabrielle Masson
Podcast
AbbVie keeps M&A rolling, FDA’s reversal train chugs along, BIO 2026 dispatch, more
June 24, 2026
·
1 min read
·
Jef Akst
Mergers & acquisitions
Serapha takes reverse merger route to Nasdaq with $230M and gene editor from China
June 24, 2026
·
2 min read
·
Tristan Manalac
Business
Takeda enters transitional year as new CEO seeks return to growth
June 24, 2026
·
2 min read
·
Tristan Manalac
